Caution Notice:
It has come to our notice that certain fraudulent individuals or entities are misusing our Company’s name and TCI’s registered trademarks by promoting and offering for sale regulated and hazardous chemical substances, including Potassium Cyanide, through online platforms like YouTube. We hereby categorically clarify that TCI has no association or connection whatsoever with the products being displayed or sold in these or similar videos. These products have been falsely represented as being associated with TCI, and the unauthorized use of our trademark and brand name is both illegal and misleading. TCI Chemicals is a responsible global organization committed to adhering to all applicable international and domestic regulatory frameworks. We do not manufacture, distribute, or engage in the sale of regulated chemical substances in India or in any other jurisdiction unless specifically authorized by the relevant laws and regulatory agencies. All our operations and offerings are governed by stringent safety, quality, and compliance protocols in accordance with applicable laws. Further, TCI Chemicals markets and sells its products exclusively through its official website and authorized distributors. We do not sell, endorse, or supply our products through any third-party platforms, unauthorized agents, or resellers. Any individual or organization purchasing products outside these official channels does so at their own risk, and TCI disclaims all responsibility and liability for any consequences arising therefrom. Members of the public, customers, and partners are strongly advised to exercise caution and conduct due diligence before engaging in any transactions involving products claiming association with TCI Chemicals. The official list of our authorized distributors is publicly available and may be accessed at: https://www.tcichemicals.com/IN/en/distributor/index. We are currently pursuing appropriate legal remedies against those misusing our brand, and we reserve all rights available to us under applicable intellectual property and criminal laws. If you become aware of any such fraudulent activity or require clarification, you may reach out to us at: Sales-IN@TCIchemicals.com. Your vigilance and cooperation are essential in safeguarding the public interest and protecting the integrity of the TCI brand.
Maximum quantity allowed is 999
Please select the quantity
HDAC2 may be a New Target for Schizophrenia Treatment
Kurita et al. have reported chronic treatment with atypical antipsychotic drugs (clozapine and risperidone) decreases expression of metabotropic glutamate 2 receptor (mGlu2, also known as Grm2), restrains the therapeutic effects of atypical antipsychotic drugs, and acetylates histone at its promoter gene in the mouse and human frontal cortex. They have also shown that additional treatment with SAHA as a histone deacetylase (HDAC) inhibitor prevents this decrease in mGlu2, and augments the behavioral effects of atypical antipsychotics drugs. These data suggest that HDAC2 may be a new therapeutic target to augment the treatment of schizophrenia. (Notice that these products are for research purpose only.)
References
- HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity